Involvement of Environmental Mercury and Lead in the Etiology of Neurodegenerative Diseases
暂无分享,去创建一个
Florianne Monnet-Tschudi | Paul Honegger | Marie-Gabrielle Zurich | M. Zurich | P. Honegger | F. Monnet-Tschudi | Corina Boschat | Anne Corbaz | A. Corbaz | C. Boschat
[1] J. Loike,et al. Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils , 1996, Nature.
[2] G. Bratton,et al. Cellular targets of lead neurotoxicity: in vitro models. , 1986, Toxicology.
[3] M. Zurich,et al. Neurotoxicant-induced inflammatory response in three-dimensional brain cell cultures , 2007, Human & experimental toxicology.
[4] Todd B. Sherer,et al. Mechanism of Toxicity in Rotenone Models of Parkinson's Disease , 2003, The Journal of Neuroscience.
[5] Chantra Eskes,et al. Maturation‐dependent neurotoxicity of lead acetate in vitro: Implication of glial reactions , 2002, Journal of neuroscience research.
[6] M. Cini,et al. Studies on lipid peroxidation and protein oxidation in the aging brain , 1995, Neurobiology of Aging.
[7] T. Burbacher,et al. Increases in the number of reactive glia in the visual cortex of Macaca fascicularis following subclinical long-term methyl mercury exposure. , 1994, Toxicology and applied pharmacology.
[8] M. Navarro,et al. Levels of selected metals in ambient air PM10 in an urban site of Zaragoza (Spain). , 2005, Environmental research.
[9] M. Cameron Sullards,et al. Oxidative Damage of DJ-1 Is Linked to Sporadic Parkinson and Alzheimer Diseases* , 2006, Journal of Biological Chemistry.
[10] R. Veerhuis,et al. How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes , 2004, Aging cell.
[11] M. Gilbert,et al. Chronic developmental lead exposure reduces neurogenesis in adult rat hippocampus but does not impair spatial learning. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.
[12] G. Leuba,et al. Involvement of microglia–neuron interactions in the tumor necrosis factor‐α release, microglial activation, and neurodegeneration induced by trimethyltin , 2003, Journal of neuroscience research.
[13] D. Cory-Slechta. Studying toxicants as single chemicals: does this strategy adequately identify neurotoxic risk? , 2005, Neurotoxicology.
[14] K. Breen,et al. The interaction between chronic low-level lead and the amyloid beta precursor protein. , 1998, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[15] D. Butterfield,et al. In vitro and in vivo oxidative stress associated with Alzheimer's amyloid beta-peptide (1-42) , 1999, Neurobiology of aging.
[16] David M. Umbach,et al. Lead Exposure and Amyotrophic Lateral Sclerosis , 2002, Epidemiology.
[17] C. Hock,et al. Mercury Induces Cell Cytotoxicity and Oxidative Stress and Increases β‐Amyloid Secretion and Tau Phosphorylation in SHSY5Y Neuroblastoma Cells , 2000, Journal of neurochemistry.
[18] D. Butterfield,et al. Amyloid β-peptide inhibits Na+-dependent glutamate uptake , 1999 .
[19] W. Streit. Microglia and neuroprotection: implications for Alzheimer's disease , 2005, Brain Research Reviews.
[20] M. Allam,et al. Parkinson's disease risk factors: genetic, environmental, or both? , 2005, Neurological research.
[21] J. Coyle,et al. Oxidative stress in neurodegenerative diseases. , 1996, Annual review of pharmacology and toxicology.
[22] G. Sandborgh-Englund,et al. Mercury in saliva and feces after removal of amalgam fillings. , 1997, Toxicology and applied pharmacology.
[23] Florianne Monnet-Tschudi,et al. Microglial responsiveness as a sensitive marker for trimethyltin (TMT) neurotoxicity , 1995, Brain Research.
[24] Hui Yang,et al. Environmental toxins and α-synuclein in Parkinson’s disease , 2007, Molecular Neurobiology.
[25] W. Streit,et al. Microglia and Alzheimer's disease pathogenesis , 2004, Journal of neuroscience research.
[26] T. Sherer,et al. Environment, Mitochondria, and Parkinson's Disease , 2002, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[27] John F Rosen,et al. Low-level lead-induced neurotoxicity in children: an update on central nervous system effects , 1998, Brain Research Reviews.
[28] F. Tsang,et al. Interactions Between Environmental and Genetic Factors in the Pathophysiology of Parkinson's Disease , 2003, IUBMB life.
[29] M. Zurich,et al. Comparison of the developmental effects of two mercury compounds on glial cells and neurons in aggregate cultures of rat telencephalon , 1996, Brain Research.
[30] T. Burbacher,et al. Changes in the number of astrocytes and microglia in the thalamus of the monkey Macaca fascicularis following long-term subclinical methylmercury exposure. , 1996, Neurotoxicology.
[31] J. O'Callaghan. Neurotypic and gliotypic proteins as biochemical markers of neurotoxicity. , 1988, Neurotoxicology and teratology.
[32] E. Nisbet,et al. Can diamonds be dead bacteria? , 1994, Nature.
[33] N. Fullwood,et al. Protein aggregation, metals and oxidative stress in neurodegenerative diseases. , 2005, Biochemical Society transactions.
[34] G. Bratton,et al. Differential ability of astroglia and neuronal cells to accumulate lead: dependence on cell type and on degree of differentiation. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.
[35] W. Tatton,et al. Etiology and pathogenesis of Parkinson's disease. , 1999, Annual review of neuroscience.
[36] G. Schettini,et al. The amyloid precursor protein and its network of interacting proteins: physiological and pathological implications , 2005, Brain Research Reviews.
[37] J. O'Callaghan,et al. Glial fibrillary acidic protein and related glial proteins as biomarkers of neurotoxicity , 2005, Expert opinion on drug safety.
[38] B. Schilter,et al. Increased vulnerability of neurones and glial cells to low concentrations of methylmercury in a prooxidant situation , 1998, Acta Neuropathologica.
[39] J. O'Callaghan,et al. Differential activation of microglia and astrocytes following trimethyl tin-induced neurodegeneration , 1996, Neuroscience.
[40] B. Schilter,et al. The Use of Serum-Free Aggregating Brain Cell Cultures in Neurotoxicology , 1995 .
[41] F. Maxfield,et al. Slow Degradation of Aggregates of the Alzheimer’s Disease Amyloid β-Protein by Microglial Cells* , 1997, The Journal of Biological Chemistry.
[42] M. Zurich,et al. Lead acetate toxicity in vitro: Dependence on the cell composition of the cultures. , 1998, Toxicology in vitro : an international journal published in association with BIBRA.
[43] R. Mrak,et al. Glial cytokines in Alzheimer's disease: review and pathogenic implications. , 1995, Human pathology.
[44] S. Kohsaka,et al. Microglia: neuroprotective and neurotrophic cells in the central nervous system. , 2004, Current drug targets. Cardiovascular & haematological disorders.
[45] Ashima Bhan,et al. Mercury in the Environment: Effect on Health and Reproduction , 2005, Reviews on environmental health.
[46] D. Carpenter. Effects of metals on the nervous system of humans and animals. , 2001, International journal of occupational medicine and environmental health.
[47] D. Butterfield,et al. Amyloid beta-peptide inhibits Na+-dependent glutamate uptake. , 1999, Life sciences.
[48] D. Sparks,et al. Activation of microglia in the brains of humans with heart disease and hypercholesterolemic rabbits , 1996, Journal of Molecular Medicine.
[49] B. Bergamasco,et al. Modifications of the iron–neuromelanin system in Parkinson's disease , 2006, Journal of neurochemistry.
[50] C. Kaltschmidt,et al. NF-kB: a crucial transcription factor for glial and neuronal cell function , 1997, Trends in Neurosciences.
[51] C. Behl,et al. Concepts for the treatment of Alzheimer's disease: molecular mechanisms and clinical application , 2005, International journal of experimental pathology.
[52] Y. Dunant,et al. Acetylcholine release and the cholinergic genomic locus , 1998, Molecular Neurobiology.
[53] M. Mattson,et al. Secreted forms of beta-amyloid precursor protein protect against ischemic brain injury. , 1994, Journal of neurochemistry.
[54] F. Maxfield,et al. Microglial Cells Internalize Aggregates of the Alzheimer's Disease Amyloid β-Protein Via a Scavenger Receptor , 1996, Neuron.
[55] H. Walach,et al. Alzheimer disease: mercury as pathogenetic factor and apolipoprotein E as a moderator. , 2004, Neuro endocrinology letters.
[56] Cytotoxicity of microglia , 1993 .
[57] M. Zurich,et al. Evaluation of the toxicity of different metal compounds in the developing brain using aggregating cell cultures as a model. , 1993, Toxicology in vitro : an international journal published in association with BIBRA.
[58] R. Mrak,et al. Inflammatory Pathways: Implications in Alzheimer's Disease , 1996 .
[59] L. Murri,et al. Causative and susceptibility genes for Alzheimer’s disease: a review , 2003, Brain Research Bulletin.
[60] S. Hirai,et al. Expression of APP in the early stage of brain damage , 1991, Brain Research.
[61] W. Streit,et al. Reactive microgliosis , 1999, Progress in Neurobiology.
[62] Y. Christen,et al. Oxidative stress and Alzheimer disease. , 2000, The American journal of clinical nutrition.
[63] M. Johnstone,et al. A central role for astrocytes in the inflammatory response to β-amyloid; chemokines, cytokines and reactive oxygen species are produced , 1999, Journal of Neuroimmunology.
[64] J. Olson,et al. Lead toxicity in primary cultured cerebral astrocytes and cerebellar granular neurons. , 1987, Toxicology and applied pharmacology.
[65] T. Mandybur,et al. Astrocytes and the plaques of Alzheimer's disease , 1990, Neurology.
[66] J. Olson,et al. Maturation of resistance to lead encephalopathy: cellular and subcellular mechanisms. , 1984, Neurotoxicology.
[67] G. Benzi,et al. Age- and peroxidative stress-related modifications of the cerebral enzymatic activities linked to mitochondria and the glutathione system. , 1995, Free radical biology & medicine.
[68] S. Paul,et al. The NF-κB/Rel family of proteins mediates Aβ-induced neurotoxicity and glial activation , 1998 .
[69] J. Garrido,et al. Amyloid precursor protein proteoglycan is increased after brain damage. , 1998, Biochimica et biophysica acta.
[70] G. Kreutzberg. Microglia: a sensor for pathological events in the CNS , 1996, Trends in Neurosciences.
[71] Chantra Eskes,et al. Microglial reaction induced by noncytotoxic methylmercury treatment leads to neuroprotection via interactions with astrocytes and IL‐6 release , 2002, Glia.
[72] Philip J. Landrigan,et al. Early Environmental Origins of Neurodegenerative Disease in Later Life , 2005, Environmental health perspectives.
[73] R Brookmeyer,et al. Age-specific incidence rates of Alzheimer’s disease , 2000, Neurology.
[74] M. Mattson. Secreted forms of beta-amyloid precursor protein modulate dendrite outgrowth and calcium responses to glutamate in cultured embryonic hippocampal neurons. , 1994, Journal of neurobiology.
[75] L. Costa,et al. Aggregating Brain Cell Cultures for Neurotoxicological Studies , 2004 .
[76] W. Griffin,et al. Glial‐Neuronal Interactions in Alzheimer's Disease: The Potential Role of a ‘Cytokine Cycle’ in Disease Progression , 1998, Brain pathology.
[77] M. Aschner,et al. Astrocytes as mediators of immune and inflammatory responses in the CNS. , 1998, Neurotoxicology.
[78] M. Verity,et al. Oxidative mechanisms underlying methyl mercury neurotoxicity , 1991, International Journal of Developmental Neuroscience.
[79] G. Borsani,et al. NF‐κB pathway: a target for preventing β‐amyloid (Aβ)‐induced neuronal damage and Aβ42 production , 2006, The European journal of neuroscience.
[80] A. Harvey,et al. Chronic gliosis triggers Alzheimer’s disease-like processing of amyloid precursor protein , 2002, Neuroscience.
[81] M. Smith,et al. Oxidative stress mechanisms and potential therapeutics in Alzheimer disease , 2005, Journal of Neural Transmission.
[82] D. Butterfield,et al. Proteomics in Alzheimer's disease: insights into potential mechanisms of neurodegeneration , 2003, Journal of neurochemistry.
[83] Louis W. Chang. The Concept of Direct and Indirect Neurotoxicity and the Concept of Toxic Metal/Essential Element Interactions as a Common Biomechanism Underlying Metal Toxicity , 1992 .
[84] G. Benzi,et al. Are reactive oxygen species involved in Alzheimer's disease? , 1995, Neurobiology of Aging.
[85] J. Growdon,et al. Increased blood mercury levels in patients with Alzheimer's disease , 1998, Journal of Neural Transmission.
[86] Ram Naresh,et al. Blood lead levels in lactating cows reared around polluted localities; transfer of lead into milk. , 2005, The Science of the total environment.
[87] B. Riederer,et al. Effects of trimethyltin (TMT) on glial and neuronal cells in aggregate cultures: dependence on the developmental stage. , 1995, Neurotoxicology.
[88] E. Tiffany-Castiglioni,et al. Cell culture models for lead toxicity in neuronal and glial cells. , 1993, Neurotoxicology.
[89] D. Borchelt,et al. Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid β peptide in APPswe transgenic mice , 2003, Neurobiology of Disease.
[90] V. Bolivar,et al. Young brains on lead: adult neurological consequences? , 2005, Toxicological sciences : an official journal of the Society of Toxicology.
[91] B. Giasson. Mitochondrial injury: a hot spot for parkinsonism and Parkinson's disease? , 2004, Science of aging knowledge environment : SAGE KE.
[92] A. Planas,et al. MPP+ Injection into Rat Substantia Nigra Causes Secondary Glial Activation but Not Cell Death in the Ipsilateral Striatum , 2000, Neurobiology of Disease.
[93] V. Yong,et al. Astrocyte reactivity in neonatal mice: apparent dependence on the presence of reactive microglia/macrophages , 1996, Glia.
[94] M. Smith,et al. Genetic evidence for oxidative stress in Alzheimer's disease. , 1999, Neuroreport.
[95] M. Sawada,et al. Inflammatory process in Parkinson's disease: role for cytokines. , 2005, Current pharmaceutical design.
[96] J. Gorell,et al. Occupational Metal Exposures and the Risk of Parkinson’s Disease , 1999, Neuroepidemiology.
[97] L. Costa,et al. Involvement of glial cells in the neurotoxicity of parathion and chlorpyrifos. , 2004, Toxicology and applied pharmacology.
[98] C. Levenson. Iron and Parkinson's disease: chelators to the rescue? , 2003, Nutrition reviews.
[99] G. Kreutzberg,et al. Microglia, the first line of defence in brain pathologies. , 1995, Arzneimittel-Forschung.
[100] S. Shankar,et al. Aluminium in Alzheimer’s disease: are we still at a crossroad? , 2004, Cellular and Molecular Life Sciences CMLS.
[101] A. Fontana,et al. Astrocytes and lymphocytes: Intercellular communication by growth factors , 1982, Journal of neuroscience research.
[102] N. Holbrook,et al. Oxidants, oxidative stress and the biology of ageing , 2000, Nature.
[103] O'Callaghan Jp,et al. Assessment of neurotoxicity: use of glial fibrillary acidic protein as a biomarker. , 1991, Biomedical and environmental sciences : BES.
[104] M. Zurich,et al. Long-term treatment of aggregating brain cell cultures with low concentrations of lead acetate. , 1994, Neurotoxicology.
[105] J. Gutteridge. Hydroxyl Radicals, Iron, Oxidative Stress, and Neurodegeneration a , 1994, Annals of the New York Academy of Sciences.
[106] B. Hyman,et al. Neuroanatomy of Alzheimer's disease: Hierarchical vulnerability and neural system compromise , 1995, Neurobiology of Aging.
[107] K. Jellinger,et al. A post mortem study on neurochemical markers of dopaminergic, GABA-ergic and glutamatergic neurons in basal ganglia-thalamocortical circuits in Parkinson syndrome , 1996, Brain Research.
[108] B. Wolozin,et al. Pathological proteins in Parkinson’s disease , 2007, Journal of Molecular Neuroscience.
[109] Vellareddy Anantharam,et al. Dieldrin-induced neurotoxicity: relevance to Parkinson's disease pathogenesis. , 2005, Neurotoxicology.
[110] R. Hickel,et al. Systemic transfer of mercury from amalgam fillings before and after cessation of emission. , 1998, Environmental research.
[111] S. Bondy,et al. Reactive oxygen species formation as a biomarker of methylmercury and trimethyltin neurotoxicity. , 1992, Neurotoxicology.
[112] Roberto Cappai,et al. Metals and amyloid‐β in Alzheimer's disease , 2005, International journal of experimental pathology.
[113] K. Breen,et al. The role of glycoproteins in neural development, function, and disease , 1998, Molecular Neurobiology.
[114] Georg W. Kreutzberg,et al. Neuroglial activation repertoire in the injured brain: graded response, molecular mechanisms and cues to physiological function , 1999, Brain Research Reviews.
[115] M. Rathbone,et al. Involvement of astrocytes in purine-mediated reparative processes in the brain , 2001, International Journal of Developmental Neuroscience.
[116] Y. K. Fung,et al. Brain mercury in neurodegenerative disorders. , 1997, Journal of toxicology. Clinical toxicology.
[117] D. Selkoe,et al. Toward a Comprehensive Theory for Alzheimer's Disease. Hypothesis: Alzheimer's Disease Is Caused by the Cerebral Accumulation and Cytotoxicity of Amyloid β‐Protein , 2000, Annals of the New York Academy of Sciences.
[118] Hui Yang,et al. Environmental toxins and alpha-synuclein in Parkinson's disease. , 2005, Molecular neurobiology.
[119] M. Mattson,et al. Secreted Forms of β‐Amyloid Precursor Protein Protect Against Ischemic Brain Injury , 1994 .
[120] J. Kordower,et al. Etiology of Parkinson's disease: Genetics and environment revisited , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[121] S. Paul,et al. The NF-kappaB/Rel family of proteins mediates Abeta-induced neurotoxicity and glial activation. , 1998, Brain research. Molecular brain research.